BlackRock reports 1.8% stake in Pulmonx Corp
BlackRock, Inc. filed an amended Schedule 13G reporting its beneficial ownership of Pulmonx Corp common stock.
Rhea-AI Filing Summary
BlackRock, Inc. filed an amended Schedule 13G reporting its beneficial ownership of Pulmonx Corp common stock. BlackRock reports beneficial ownership of 765,721 shares of common stock, representing 1.8% of the class.
BlackRock has sole voting power and sole dispositive power over all 765,721 shares, with no shared voting or dispositive power. Various underlying clients have rights to dividends or sale proceeds, but no single client holds more than five percent of Pulmonx’s outstanding common shares.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
sole dispositive power financial
Schedule 13G regulatory
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Pulmonx Corp (LUNG) does BlackRock currently report owning?
Why is BlackRock’s Pulmonx (LUNG) holding reported on Schedule 13G/A as 5% or less?
Who ultimately benefits from BlackRock’s Pulmonx Corp (LUNG) holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.